ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Featuring an interview with Dr Seth Wander, including the following topics:

ASCO Guidelines Rapid Recommendations Update for Testing for ESR1 Mutations (0:00)

Real-world elacestrant use patterns and genomic biomarkers (4:43)

Circulating tumor DNA (ctDNA) analyses with imlunestrant in the EMBER Phase I study (8:50)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.